According to the Birmingham Mail<\/a>, the Department of Health and Social Care has confirmed that the trial is taking place at 39 hospitals across the UK. The programme focuses on patients requiring a radiotherapy boost, an additional dose directed at the area where their tumour was removed.<\/p>\n\n\n\n The Institute of Cancer Research<\/a> states that the study aims to recruit 4,830 patients, who will be allocated to one of three treatment groups. One group will receive the standard 15-day course, while the other two will undergo five days of radiotherapy using different boost doses.<\/p>\n\n\n\n Of those participants, 1,610 will receive the standard treatment and 3,220 will receive one of the shorter courses. Researchers will assess whether the five-day approach can match the longer schedule in preventing cancer from returning while monitoring potential side effects.<\/p>\n\n\n\n Health Secretary Yvette Cooper welcomed the programme, describing it as an example of British research being used to improve cancer treatment.<\/p>\n\n\n\n “This programme is aiming to radically shorten the treatment times for breast cancer – to support patients and save more lives<\/em>,” she said.<\/p>\n\n\n\n Participants will undergo regular assessments during and after treatment. The first 345 patients<\/strong> will also receive additional monitoring for early side effects, including changes affecting the skin, breast and oesophagus.<\/p>\n\n\n\n The FAST-Forward Boost <\/strong>study builds on earlier British research that changed how breast cancer radiotherapy is delivered.<\/p>\n\n\n\n![\"\"](\"https:\/\/en.econostrum.info\/uk\/wp-content\/uploads\/sites\/6\/2026\/10\/NHS-trial-tests-five-day-breast-cancer-radiotherapy-in-4830-patients-\u00a9Canva-1200x727.jpg\")
Previous Research Supports Shorter Treatment, but Questions Remain<\/strong><\/h2>\n\n\n\n